Non-invasive Stroke Volume-based fluid Management in Elderly Patients Undergoing Hip Fracture Surgery Under Spinal Anaesthesia
AttikonHSV
1 other identifier
interventional
30
1 country
2
Brief Summary
The study is going to be a single-centre prospective randomized trial. Patients will be randomly allocated to either control group (anesthetist-directed fluid therapy) or goal directed fluid therapy group, in which fluid therapy was guided by stoke volume (SV) algorithm with the use of Nexfin monitor. Primary outcome measures were the time to hospital discharge since surgery and the occurence of complications developed during the postoperative period. Secondary outcomes included the incidence of intraoperative hypotensive episodes (with MAP\<65mmHg) in both groups and the requirement of vasoactive drugs to support blood pressure
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2018
CompletedFirst Submitted
Initial submission to the registry
June 5, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedJune 9, 2020
June 1, 2020
3.9 years
June 5, 2020
June 5, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
days of hospitalization after surgery
days of hospitalization after the operation
30 days
complications
incidence of complications
30 days
Secondary Outcomes (2)
hypotension
during surgery
use of vasoactive agents
during surgery
Study Arms (2)
Control group
ACTIVE COMPARATORControl group Management of the hemodynamic status in the control group will be performed in the discretion of the attending anesthesiologist, with the aim of keeping mean arterial pressure (MAP) \> 65mmHg. The type and amount of delivered fluids, and vasoactive or inotropic drugs will be recorded.
GDFM
ACTIVE COMPARATORGoal-directed fluid management group (GDFM). . Baseline SV will be measured after the patients will be turned to left/right position \& before implementation of regional anesthesia. Fluid challenges of 250 ml will be repeated until SV fails to increase by 10%. At this point, preload is considered optimized and SV optimum is defined. SV trigger is defined as SV opt - 10%. N/S 250ml boluses will be administered when SV is below SV trigger. Inotropic drugs will be administered (dobutamine infusion at 0.2-10mcg/kg/min) if CO is below 3.5 L/min and vasopressors (phenylephrine bolus doses of 50-100mcg) if SV and CO are within the target range but MAP is below 65mmHg. Patients will be reassessed during the intraoperative period every 10 minutes . Except from the fluid boluses, all patients will be administered Ringer's lactate solution at an infusion rate of 2ml/kg/h.
Interventions
Eligibility Criteria
You may qualify if:
- Patients scheduled for hip fracture repair
- over 60 years of age
- American Society of Anesthesiologists (ASA) physical status II, III, IV
You may not qualify if:
- refusal or inability to consent,
- a plan for general anesthesia
- expected unreliable measurements of nexfin monitor (e.g. peripheral vascular disease, finger edema).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Attikon Hospitallead
Study Sites (2)
2nd Department of Anaesthesiology, Attikon Hospital, 1 Rimini str.
Athens, Attica, 12462, Greece
2nd Department of Anesthesiology, Attikon Hospital, 1 Rimini str.
Athens, 12462, Greece
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Anaesthesiology
Study Record Dates
First Submitted
June 5, 2020
First Posted
June 9, 2020
Study Start
January 15, 2018
Primary Completion
November 30, 2021
Study Completion
December 30, 2021
Last Updated
June 9, 2020
Record last verified: 2020-06